Showing results (271-280 of 285) with videos related to
Sort By:
Pageof 29
Scientific Reports|July 5, 2017
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individualsBenedetta Donati, Paola Dongiovanni, Stefano Romeo, et al.Journal of Hepatology|April 4, 2020
Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosisAngelo Sangiovanni, Eleonora Alimenti, Riccardo Gattai, et al.Hepatology (Baltimore, Md.)|June 17, 2017
The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis BGeorge V Papatheodoridis, Ramazan Idilman, George N Dalekos, et al.Journal of Hepatology|December 13, 2021
The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?Jeffrey V Lazarus, Henry E Mark, Marcela Villota-Rivas, et al.Journal of Hepatology|February 11, 2018
Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general populationGeorge V Papatheodoridis, Vana Sypsa, George Dalekos, et al.The Lancet. Infectious Diseases|February 25, 2016
Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trialMichael Manns, Didier Samuel, Edward J Gane, et al.Journal of Hepatology|April 18, 2016
Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinomaGhassan K Abou-Alfa, Oscar Puig, Bruno Daniele, et al.Journal of Hepatology|October 27, 2016
Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradicationAdriaan J van der Meer, Jordan J Feld, Harald Hofer, et al.Journal of Hepatology|June 11, 2018
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030Chris Estes, Quentin M Anstee, Maria Teresa Arias-Loste, et al.Nature Communications|August 29, 2024
An atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infectionAtish Mukherji, Frank Jühling, Yogy Simanjuntak, et al.Pageof 29